{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:13:50Z","timestamp":1792725230956,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012507","name":"St George and Sutherland Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012507","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jaut.2021.102747","type":"journal-article","created":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T18:22:14Z","timestamp":1637000534000},"page":"102747","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["\u0392eta-2-glycoprotein I exerts antithrombotic function through its domain V in mice"],"prefix":"10.1016","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4584-2044","authenticated-orcid":false,"given":"Freda H.","family":"Passam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivien M.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Krilis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bill","family":"Giannakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2021.102747_bib1","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJMra0801082","article-title":"Mechanisms of thrombus formation","volume":"359","author":"Furie","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2021.102747_bib2","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.it.2004.08.003","article-title":"Interactions between the innate immune and blood coagulation systems","volume":"25","author":"Esmon","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jaut.2021.102747_bib3","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1182\/blood-2009-05-199208","article-title":"Coagulation and innate immune responses: can we view them separately?","volume":"114","author":"Delvaeye","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2021.102747_bib4","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nm.2184","article-title":"Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases","volume":"16","author":"Massberg","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2021.102747_bib5","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1084\/jem.20112322","article-title":"Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo","volume":"209","author":"von Br\u00fchl","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2021.102747_bib6","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1182\/blood-2012-06-437772","article-title":"Tissue factor-positive neutrophils bind to injured endothelial wall and initiate thrombus formation","volume":"120","author":"Darbousset","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2021.102747_bib7","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1182\/blood-2014-04-571679","article-title":"P2X1 expressed on polymorphonuclear neutrophils and platelets is required for thrombosis in mice","volume":"124","author":"Darbousset","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2021.102747_bib8","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1538-7836.2011.04544.x","article-title":"Neutrophil extracellular traps promote deep vein thrombosis in mice","volume":"10","author":"Brill","year":"2012","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.jaut.2021.102747_bib9","doi-asserted-by":"crossref","first-page":"27123","DOI":"10.1016\/S0021-9258(19)61488-2","article-title":"Matrix metalloproteinases cleave tissue factor pathway inhibitor. Effects on coagulation","volume":"275","author":"Belaaouaj","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2021.102747_bib10","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMra1112830","article-title":"The pathogenesis of the antiphospholipid syndrome","volume":"368","author":"Giannakopoulos","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2021.102747_bib11","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1074\/jbc.M110176200","article-title":"Heparin inhibits the binding of beta 2-glycoprotein I to phospholipids and promotes the plasmin-mediated inactivation of this blood protein. Elucidation of the consequences of the two biological events in patients with the anti-phospholipid syndrome","volume":"277","author":"Guerin","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2021.102747_bib12","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1074\/jbc.M410291200","article-title":"Domain V of beta2-glycoprotein I binds factor XI\/XIa and is cleaved at Lys317-Thr318","volume":"280","author":"Shi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2021.102747_bib13","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/art.22367","article-title":"Beta2-glycoprotein I binds thrombin via exosite I and exosite II: anti-beta2-glycoprotein I antibodies potentiate the inhibitory effect of beta2-glycoprotein I on thrombin-mediated factor XIa generation","volume":"56","author":"Rahgozar","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102747_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1006\/jaut.2000.0427","article-title":"Epitope studies with anti-beta 2-glycoprotein I antibodies from autoantibody and immunized sources","volume":"15","author":"Reddel","year":"2000","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2021.102747_bib15","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1182\/blood-2004-09-3387","article-title":"IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis","volume":"105","author":"de Laat","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2021.102747_bib16","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1182\/blood-2010-08-300715","article-title":"\u03b2\u2082-Glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model","volume":"117","author":"Arad","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2021.102747_bib17","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/MOH.0000000000000067","article-title":"Recent advances in the antiphospholipid antibody syndrome","volume":"21","author":"Chaturvedi","year":"2014","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.jaut.2021.102747_bib18","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2005-03-1319","article-title":"Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor","volume":"106","author":"Fischetti","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2021.102747_bib19","doi-asserted-by":"crossref","first-page":"15542","DOI":"10.1073\/pnas.95.26.15542","article-title":"Anti-beta2 glycoprotein I (beta2GPI) autoantibodies recognize an epitope on the first domain of beta2GPI","volume":"95","author":"Iverson","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2021.102747_bib20","doi-asserted-by":"crossref","first-page":"13817","DOI":"10.1074\/jbc.M010990200","article-title":"Impaired thrombin generation in beta 2-glycoprotein I null mice","volume":"276","author":"Sheng","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2021.102747_bib21","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1182\/blood-2010-04-278184","article-title":"Endothelium-derived but not platelet-derived protein disulfide isomerase is required for thrombus formation in vivo","volume":"116","author":"Jasuja","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2021.102747_bib22","article-title":"Real-time imaging of heterotypic platelet-neutrophil interactions on the activated endothelium during vascular inflammation and thrombus formation in live mice","volume":"74","author":"Kim","year":"2013","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.jaut.2021.102747_bib23","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1046\/j.1365-2249.2001.01555.x","article-title":"Detection of 'antiphospholipid' antibodies: a single chromogenic assay of thrombin generation sensitively detects lupus anticoagulants, anticardiolipin antibodies, plus antibodies binding beta(2)-glycoprotein I and prothrombin","volume":"124","author":"Sheng","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2021.102747_bib24","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1055\/s-0038-1648517","article-title":"Beta 2-glycoprotein I deficiency and the risk of thrombosis","volume":"67","author":"Bancsi","year":"1992","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.jaut.2021.102747_bib25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0021-9150(99)00496-7","article-title":"beta(2)-glycoprotein I deficiency: prevalence, genetic background and effects on plasma lipoprotein metabolism and hemostasis","volume":"152","author":"Yasuda","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jaut.2021.102747_bib26","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1182\/blood-2009-03-212910","article-title":"Association between beta2-glycoprotein I plasma levels and the risk of myocardial infarction in older men","volume":"114","author":"de Laat","year":"2009","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.jaut.2021.102747_bib27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1191\/0961203306lu2270oa","article-title":"Circulating levels of beta2-glycoprotein I in thrombotic disorders and in inflammation","author":"Lin","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2021.102747_bib28a","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/jth.12679","article-title":"Identification of APOH polymorphisms as common genetic risk factors for venous thrombosis in the Chinese population","volume":"12","author":"Tang","year":"2014","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.jaut.2021.102747_bib28b","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1182\/blood-2018-10-862243","article-title":"Neutrophils: back in the thrombosis spotlight","volume":"133","author":"Noubouossie","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2021.102747_bib29","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/nature04226","article-title":"A haplotype map of the human genome","volume":"437","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2021.102747_bib30","doi-asserted-by":"crossref","first-page":"15880","DOI":"10.1073\/pnas.1005743107","article-title":"Extracellular DNA traps promote thrombosis","volume":"107","author":"Fuchs","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2021.102747_bib31","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1016\/j.febslet.2010.06.006","article-title":"Activated endothelial cells induce neutrophil extracellular traps and are susceptible to NETosis-mediated cell death","volume":"584","author":"Gupta","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jaut.2021.102747_bib32","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1136\/annrheumdis-2013-204837","article-title":"Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2","volume":"74","author":"Carmona-Rivera","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2021.102747_bib33","article-title":"The fifth domain of beta 2 glycoprotein I protects from natural IgM mediated cardiac ischaemia reperfusion injury","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2021.102747_bib34","doi-asserted-by":"crossref","first-page":"647785","DOI":"10.3389\/fcvm.2021.647785","article-title":"Post-ischemic myocardial inflammatory response: a complex and dynamic process susceptible to immunomodulatory therapies","volume":"8","author":"Pluijmert","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.jaut.2021.102747_bib35","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1002\/art.38646","article-title":"Deletion of the antiphospholipid syndrome autoantigen \u03b22 -glycoprotein I potentiates the lupus autoimmune phenotype in a Toll-like receptor 7-mediated murine model","volume":"66","author":"Giannakopoulos","year":"2014","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2021.102747_bib36","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1182\/blood-2011-02-339564","article-title":"\u03b2\u2082-glycoprotein I, the major target in antiphospholipid syndrome, is a special human complement regulator","volume":"118","author":"Gropp","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2021.102747_bib37","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1006\/jaut.1994.1024","article-title":"Exposure of anionic phospholipids upon platelet activation permits binding of beta 2 glycoprotein I and through it that of IgG antiphospholipid antibodies. Studies in platelets from patients with antiphospholipid syndrome and normal subjects","volume":"7","author":"V\u00e1zquez-Mellado","year":"1994","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2021.102747_bib38","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1182\/blood-2007-07-100008","article-title":"Excessive exposure to anionic surfaces maintains autoantibody response to beta(2)-glycoprotein I in patients with antiphospholipid syndrome","volume":"110","author":"Yamaguchi","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2021.102747_bib39","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1073\/pnas.0400281101","article-title":"Beta 2-Glycoprotein I binds factor XI and inhibits its activation by thrombin and factor XIIa: loss of inhibition by clipped beta 2-glycoprotein I","volume":"101","author":"Shi","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2021.102747_bib40","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1182\/blood-2006-10-053199","article-title":"beta2-Glycoprotein I inhibits von Willebrand factor dependent platelet adhesion and aggregation","volume":"110","author":"Hulstein","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2021.102747_bib41","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1182\/blood-2008-12-190629","article-title":"Nicked {beta}2-glycoprotein I binds angiostatin 4.5 (plasminogen kringle 1-5) and attenuates its antiangiogenic property","volume":"114","author":"Nakagawa","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2021.102747_bib42","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1182\/blood-2003-08-2712","article-title":"Nicked beta2-glycoprotein I: a marker of cerebral infarct and a novel role in the negative feedback pathway of extrinsic fibrinolysis","volume":"103","author":"Yasuda","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2021.102747_bib43","doi-asserted-by":"crossref","first-page":"6939","DOI":"10.1182\/blood-2010-12-325951","article-title":"\u03b2\u2082-glycoprotein I: a novel component of innate immunity","volume":"117","author":"Agar","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2021.102747_bib44","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1182\/blood-2014-02-554980","article-title":"Platelets are required for enhanced activation of the endothelium and fibrinogen in a mouse thrombosis model of APS","volume":"124","author":"Proulle","year":"2014","journal-title":"Blood"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841121001554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841121001554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:28:40Z","timestamp":1760257720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841121001554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":45,"alternative-id":["S0896841121001554"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2021.102747","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u0392eta-2-glycoprotein I exerts antithrombotic function through its domain V in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2021.102747","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102747"}}